株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

欧州の止血剤・シーラント市場 ~2024年:ブランド (Hemopatch (Baxter)、Tachosil (武田薬品工業)、Veriset (Medtronic)、Avitene (C.R Bard)、Sangustop (B Braun)、Lyostypt (B Braun))・国別の予測

European Hemostats & Sealants Market by Brand (Hemopatch (Baxter), Tachosil (Takeda), Veriset (Medtronic), Avitene (C.R Bard), Sangustop (B Braun), Lyostypt (B Braun)), Country (Germany, Uk, France, Italy & Spain) - Forecast to 2024

発行 MarketsandMarkets 商品コード 832938
出版日 ページ情報 英文 32 Pages
即納可能
価格
本日の銀行送金レート: 1USD=107.66円で換算しております。
Back to Top
欧州の止血剤・シーラント市場 ~2024年:ブランド (Hemopatch (Baxter)、Tachosil (武田薬品工業)、Veriset (Medtronic)、Avitene (C.R Bard)、Sangustop (B Braun)、Lyostypt (B Braun))・国別の予測 European Hemostats & Sealants Market by Brand (Hemopatch (Baxter), Tachosil (Takeda), Veriset (Medtronic), Avitene (C.R Bard), Sangustop (B Braun), Lyostypt (B Braun)), Country (Germany, Uk, France, Italy & Spain) - Forecast to 2024
出版日: 2019年04月12日 ページ情報: 英文 32 Pages
概要

世界の止血剤・シーラント (封止剤) 市場は、2019年には6300万米ドル、2024年には8900万米ドルと、7.0%のCAGR (複合年間成長率) で成長する見通しです。市場成長の主な要因として、手術件数の増加や、欧州域内での良好な医療費償還環境などが挙げられます。ブランド別では、Tachosilの大幅な成長が期待されています。また国別では、ドイツ市場が最大のシェアを占めています。

当レポートでは、欧州諸国の止血剤およびシーラントの市場について分析し、市場の基本構造や最新情勢、主な市場促進・阻害要因、市場動向の見通し (過去2年間・今後6年間分)、製品/ブランド別・国別の詳細動向、市場競争の状態、主要企業のプロファイルなどを調査しております。

第1章 イントロダクション

第2章 分析手法

第3章 エグゼクティブ・サマリー

第4章 市場概要

第5章 止血剤市場:製品別・国別

  • SANGUSTOP
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
  • LYOSTYPT
  • AVITENE
  • TACHOSIL
  • HEMOPATCH
  • VERISET

第6章 付録

図表

LIST OF TABLES

  • TABLE 1: EUROPEAN HEMOSTATS AND SEALANTS MARKET (USD MILLION), BY BRAND, 2017 - 2024
  • TABLE 2: EUROPEAN HEMOSTATS AND SEALANTS MARKET (USD MILLION), BY COUNTRY, 2017 - 2024
  • TABLE 3: SANGUSTOP MARKET (USD MILLION), BY COUNTRY, 2017 - 2024
  • TABLE 4: LYOSTYPT MARKET (USD MILLION), BY COUNTRY, 2017 - 2024
  • TABLE 5: AVITENE MARKET (USD MILLION), BY COUNTRY, 2017 - 2024
  • TABLE 6: TACHOSIL MARKET (USD MILLION), BY COUNTRY, 2017 - 2024
  • TABLE 7: HEMOPATCH MARKET (USD MILLION), BY COUNTRY, 2017 - 2024
  • TABLE 8: VERISET MARKET (USD MILLION), BY COUNTRY, 2017 - 2024

LIST OF FIGURES

  • FIGURE 1: BRAND MARKET, COUNTRY
  • FIGURE 2: COUNTRY PRESENCE
  • FIGURE 3: NUMBER OF RESPONDENTS, BY TYPE
  • FIGURE 4: NUMBER OF RESPONDENTS, BY COUNTRY
  • FIGURE 5: SUPPLY SIDE RESPONDENTS, BY TYPE
  • FIGURE 6: DEMAND SIDE RESPONDENTS, BY DESIGNATION
目次
Product Code: PH 7043

"European Hemostats and Sealants market to register a CAGR of 7.0% from 2019 to 2024"

The European hemostats and sealants market is projected to reach USD 89 million by 2024 from USD 63 million in 2019, at a CAGR of 7.0% during the forecast period. Growth in this market is mainly driven by the increasing number of surgical procedures and the favorable reimbursement scenario in the European region.

"Tachosil exhibited the highest CAGR over the forecast period."

By brand, the hemostats and sealants market is segmented into Tachosil, Lyostypt, Sangustop, Veriset, Avitene, and Hemopatch. Over the forecast period, Tachosil accounted for the highest CAGR. The product provides effective results in emergency cases.

"Germany exhibited the largest share in the market"

Germany accounted for the largest share in the hemostats and sealants market. The large share of this market segment can be attributed to the larger patient population and surgical procedures.

Breakdown of supply-side primary interviews, by type, designation, and country:

  • By Respondent Type: Supply (79%) and Demand (21%)
  • By Designation: Manufacturer (81%) and Distributor (19%)
  • By Country: Germany (25%), UK (21%), France (21%), Italy (18%), and Spain (15%)

Research Coverage:

This report studies the European hemostats and sealants market based on brand and countries. The report also analyzes factors (such as drivers, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total hemostats and sealants market. The report forecasts the revenue of the brands with respect to five major countries.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the hemostats and sealants offered by the top players in the hemostats and sealants market. The report analyzes the hemostats and sealants market by brand and country.
  • Market Development: Comprehensive information about the lucrative markets. The report analyzes the markets for focused hemostats and sealants across the EU5.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKETS COVERED
  • 1.3 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 ASSUMPTIONS & LIMITATIONS

2 RESEARCH METHODOLOGY

  • 2.1 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.2 FORECAST MODEL STEPS

3 EXECUTIVE SUMMARY

4 MARKET OVERVIEW

  • 4.1 RESPONDENT PROFILE
  • 4.2 INTRODUCTION
  • 4.3 MARKET DYNAMICS
  • 4.4 SEALING PRODUCTS

5 HEMOSTATS MARKET, BY PRODUCT & COUNTRY

  • 5.1 SANGUSTOP
    • 5.1.1 GERMANY
    • 5.1.2 UK
    • 5.1.3 FRANCE
    • 5.1.4 ITALY
    • 5.1.5 SPAIN
  • 5.2 LYOSTYPT
    • 5.2.1 GERMANY
    • 5.2.2 UK
    • 5.2.3 FRANCE
    • 5.2.4 ITALY
    • 5.2.5 SPAIN
  • 5.3 AVITENE
    • 5.3.1 GERMANY
    • 5.3.2 UK
    • 5.3.3 FRANCE
    • 5.3.4 ITALY
    • 5.3.5 SPAIN
  • 5.4 TACHOSIL
    • 5.4.1 GERMANY
    • 5.4.2 UK
    • 5.1.3 FRANCE
    • 5.4.4 ITALY
    • 5.4.5 SPAIN
  • 5.5 HEMOPATCH
    • 5.5.1 GERMANY
    • 5.5.2 UK
    • 5.5.3 FRANCE
    • 5.5.4 ITALY
    • 5.5.5 SPAIN
  • 5.6 VERISET
    • 5.6.1 GERMANY
    • 5.6.2 UK
    • 5.6.3 FRANCE
    • 5.6.4 ITALY
    • 5.6.5 SPAIN

6 APPENDIX

Back to Top